Cryo-Cell International Inc (CCEL)
8.56
-0.07
(-0.81%)
USD |
NYAM |
May 08, 16:00
8.56
0.00 (0.00%)
After-Hours: 20:00
Cryo-Cell International SG&A Expense (Quarterly): 4.340M for Feb. 29, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | 4.340M |
November 30, 2023 | 5.393M |
August 31, 2023 | 3.805M |
May 31, 2023 | 4.039M |
February 28, 2023 | 3.879M |
November 30, 2022 | 4.688M |
August 31, 2022 | 3.603M |
May 31, 2022 | 3.913M |
February 28, 2022 | 3.376M |
November 30, 2021 | 4.535M |
August 31, 2021 | 3.494M |
May 31, 2021 | 3.148M |
February 28, 2021 | 3.433M |
November 30, 2020 | 3.490M |
August 31, 2020 | 3.376M |
May 31, 2020 | 3.559M |
February 29, 2020 | 3.87M |
November 30, 2019 | 3.942M |
August 31, 2019 | 3.557M |
May 31, 2019 | 3.648M |
February 28, 2019 | 3.745M |
November 30, 2018 | 4.120M |
August 31, 2018 | 4.391M |
May 31, 2018 | 3.533M |
February 28, 2018 | 3.590M |
Date | Value |
---|---|
November 30, 2017 | 3.538M |
August 31, 2017 | 3.433M |
May 31, 2017 | 3.412M |
February 28, 2017 | 3.098M |
November 30, 2016 | 3.808M |
August 31, 2016 | 3.912M |
May 31, 2016 | 3.406M |
February 29, 2016 | 3.597M |
November 30, 2015 | 3.840M |
August 31, 2015 | 2.629M |
May 31, 2015 | 3.007M |
February 28, 2015 | 2.914M |
November 30, 2014 | 3.428M |
August 31, 2014 | 2.948M |
May 31, 2014 | 2.753M |
February 28, 2014 | 3.123M |
November 30, 2013 | 2.877M |
August 31, 2013 | 2.836M |
May 31, 2013 | 2.958M |
February 28, 2013 | 2.695M |
November 30, 2012 | 3.921M |
August 31, 2012 | 3.060M |
May 31, 2012 | 4.285M |
February 29, 2012 | 3.161M |
November 30, 2011 | 2.237M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.148M
Minimum
May 2021
5.393M
Maximum
Nov 2023
3.854M
Average
3.726M
Median
SG&A Expense (Quarterly) Benchmarks
American Shared Hospital Services | 1.76M |
Novo Integrated Sciences Inc | 2.864M |
Astrana Health Inc | 37.95M |
P3 Health Partners Inc | 25.15M |
Biote Corp | 26.19M |